97-18105. Manufacturer of Controlled Substances; Notice of Application

[Federal Register Volume 62, Number 132 (Thursday, July 10, 1997)]
[Notices]
[Page 37077]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-18105]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33 of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 5, 1997, U.S. Drug 
Testing, Inc., 10410 Trademark Street, Rancho Cucamongo, California 
91730, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I                          
Amphetamine (1100).........................  II                         
Methamphetamine (1105).....................  II                         
Phencyclidine (7471).......................  II                         
Benzoylecgonine (9180).....................  II                         
Morphine (9300)............................  II                         
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to make drug test kits.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than September 8, 1997.

    Dated: June 23, 1997.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-18105 Filed 7-9-97; 8:45 am]
BILLING CODE 4410-09-M